Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 5Phase 4 3Phase NA 2Phase EARLY_PHASE1 1Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3Plasma cell 1Head & Neck 1

Conditions

Venous Thromboembolism 3Neoplasms 2Venous Thrombosis 1Upper Extremity Deep Vein Thrombosis 1Thrombosis 1Multiple Myeloma 1Head and Neck Neoplasms 1Fibrosis 1Catheter-Related Infections 1Carcinoma, Hepatocellular 1

Interventions

apixaban 3Enoxaparin 2Aspirin 2sotorasib 1Rosuvastatin Calcium 1Rivaroxaban 1Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Venous Thromboembolism × apixaban × Clear all
NCT07189897 2025-10-08

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

State University of New York - Upstate Medical University

Phase 4 Recruiting
76 enrolled
Classical hematologyHead & Neck

Head and Neck Neoplasms, Thrombosis, Venous Thromboembolism

NCT06603870 2025-05-30

STREAM-Line

Ottawa Hospital Research Institute

Phase 4 Recruiting
330 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism, Catheter-Related Infections, Upper Extremity Deep Vein Thrombosis

NCT02958969 2019-12-17

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Dana-Farber Cancer Institute

Phase 4 Completed
50 enrolled 5 charts
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡